Detection of 5-hydroxymethylcytosine in genomic DNA

Diagnostic detection and precise mapping of 5-hydroxymethylcytosine modifications in genomic DNA via enzymatic digestion by PvuRts1I:

5-hydroxymethylcytosine (5-hmC) residues in the human genome have been implicated in the reprogramming of differentiated cells and are therefore potentially important markers for normal and pathologic development. The invention provides a method for determination of 5-hmC modifications with base-pair precision. Genomic DNA samples are melted into single stands, and the second strand synthesized with 5-hmC nucleotides, thus providing templates for cleavage with the endonuclease PvuRts1I. Cleavage products are identified by adapter ligation and either genome wide high-throughput sequencing for research applications, or quantitative PCR for residue specific diagnostic detection.

Further Information: PDF

Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0

Contact
Peer Biskup

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Nerve cells of blind mice retain their visual function

Nerve cells in the retina were analysed at TU Wien (Vienna) using microelectrodes. They show astonishingly stable behavior – good news for retina implants. The retina is often referred to…

State-wide center for quantum science

Karlsruhe Institute of Technology joins IQST as a new partner. The mission of IQST is to further our understanding of nature and develop innovative technologies based on quantum science by…

Newly designed nanomaterial shows promise as antimicrobial agent

Rice scientists develop nanocrystals that kill bacteria under visible light. Newly developed halide perovskite nanocrystals (HPNCs) show potential as antimicrobial agents that are stable, effective and easy to produce. After…